These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1257792)

  • 1. Complement-dependent immunoglobulin G receptor function in lymphoid cells.
    Scornik JC
    Science; 1976 May; 192(4239):563-5. PubMed ID: 1257792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors.
    Scornik JC; Drewinko B
    J Immunol; 1975 Nov; 115(5):1223-6. PubMed ID: 1176774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement (C3) receptor-bearing lymphocyte-mediated cytotoxicity and lymphotoxin responses.
    O'Neill P; Mackler BF; Wyde P
    Cell Immunol; 1975 Nov; 20(1):33-41. PubMed ID: 1081909
    [No Abstract]   [Full Text] [Related]  

  • 4. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    Goldstein IM; Kaplan HB; Radin A; Frosch M
    J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia.
    Anwar AR; Kay AB
    J Immunol; 1977 Sep; 119(3):976-82. PubMed ID: 330760
    [No Abstract]   [Full Text] [Related]  

  • 6. Opsonizing activities of IgG, IgM antibodies and the C3b inactivator-cleaved third component of complement in macrophage phagocytosis.
    Wellek B; Hahn H; Opferkuch W
    Agents Actions; 1976 Feb; 6(1-3):260-2. PubMed ID: 941799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit complement lyses tumor cells without massive C3 deposition.
    Ong GL; Shah PB; Mattes MJ
    Immunol Invest; 1996 May; 25(3):215-29. PubMed ID: 8860693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: Recurrent hematuria and mesangial deposits of IgA-IgG with lowering of serum complement in a 7-year-old boy].
    Beyer P; Freysz H; Haegy JM; Himy G
    Pediatrie; 1975; 30(5):536-7. PubMed ID: 1178281
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of the C3 receptor in antibody-dependent cytotoxicity.
    Gelfand EW
    Transplantation; 1976 Jan; 21(1):73-5. PubMed ID: 1246711
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells.
    McConnell I; Hurd CM
    Immunology; 1976 Jun; 30(6):825-33. PubMed ID: 800392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
    Perrin LH; Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1976 May; 143(5):1027-41. PubMed ID: 177712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell.
    Greenberg AH; Shen L; Walker L; Arnaiz-Villena A; Roitt IM
    Eur J Immunol; 1976 Jul; 5(7):474-80. PubMed ID: 976311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Persistent C4 deficiency in a 26-month-old girl with mesangial glomerulonephritis and deposits of IgG and C3].
    Buffatti G; Borgo G; Lupo A
    Minerva Pediatr; 1977 Mar; 29(9):593-8. PubMed ID: 876007
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic and soluble mediator responses by complement (C3) receptor-bearing lymphocytes from patients with B-cell immunodeficiency diseases.
    Mackler BF; O'Neill P; Mukhopadhyay N; Richie E; Montgomery J
    Clin Immunol Immunopathol; 1976 Nov; 6(3):279-88. PubMed ID: 1086174
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement dependence of localisation of aggregated IgG in germinal centres.
    Papamichail M; Gutierrez C; Embling P; Johnson P; Holborow EJ; Pepys MB
    Scand J Immunol; 1975; 4(4):343-47. PubMed ID: 1188323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the presence of membrane receptors for complement, IgG and the sheep erythrocyte rosetting capacity on the same human lymphocytes.
    Chiao JW; Good RA
    Eur J Immunol; 1976 Mar; 6(3):157-62. PubMed ID: 991902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody dependent cytolytic effector lymphocytes (K cells) in human blood.
    Perlmann P; Perlmann H; Larsson A; Wåhlin B
    J Reticuloendothel Soc; 1975 Apr; 17(4):241-50. PubMed ID: 1097676
    [No Abstract]   [Full Text] [Related]  

  • 20. The glomerular complement receptor in immunologically mediated renal glomerular injury.
    Gelfand MC; Shin ML; Nagle RB; Green I; Frank MM
    N Engl J Med; 1976 Jul; 295(1):10-4. PubMed ID: 1272284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.